Produced by Araxis Merge on 3/8/2018 10:14:04 AM Eastern Standard Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
# | Location | File | Last Modified |
---|---|---|---|
1 | PRE_PPS-N_v3.0.1.zip\PS_PPS_interface\src\test\resources\xml\document\test | drugCheckInputMissingElement.xml | Fri Jan 12 15:43:48 2018 UTC |
2 | PRE_PPS-N_v3.0.1.zip\PS_PPS_interface\src\test\resources\xml\document\test | drugCheckInputMissingElement.xml | Fri Mar 2 22:54:13 2018 UTC |
Description | Between Files 1 and 2 |
|
---|---|---|
Text Blocks | Lines | |
Unchanged | 2 | 426 |
Changed | 1 | 2 |
Inserted | 0 | 0 |
Removed | 0 | 0 |
Whitespace | |
---|---|
Character case | Differences in character case are significant |
Line endings | Differences in line endings (CR and LF characters) are ignored |
CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
1 | <?xml | |
2 | version = "1.0" | |
3 | encoding = "UTF-8" | |
4 | ?> | |
5 | ||
6 | <PEPSReque st | |
7 | ||
8 | xmlns:xsi= "http://ww w.w3.org/2 001/XMLSch ema-instan ce" | |
9 | ||
10 | xsi:schema Location=" gov/va/med /pharmacy/ peps/exter nal/common /preencaps ulation/vo /drug/chec k/request drugCheckS chemaInput .xsd" | |
11 | ||
12 | xmlns="gov /va/med/ph armacy/pep s/external /common/pr eencapsula tion/vo/dr ug/check/r equest" | |
13 | > | |
14 | ||
15 | ||
16 | <Header> | |
17 | ||
18 | <Time | |
19 | value="084 5" | |
20 | /> | |
21 | ||
22 | <MServer | |
23 | ||
24 | stationNum ber="45" | |
25 | ||
26 | serverName ="Server N ame" | |
27 | ||
28 | ip=" IP " | |
29 | ||
30 | uci="text" | |
31 | ||
32 | namespace= "VISTA" | |
33 | /> | |
34 | ||
35 | <MUser | |
36 | ||
37 | jobNumber= "365" | |
38 | ||
39 | duz="88660 079" | |
40 | ||
41 | userName=" user" | |
42 | /> | |
43 | ||
44 | </Header> | |
45 | ||
46 | ||
47 | <Body> | |
48 | ||
49 | <drugCheck > | |
50 | ||
51 | <checks | |
52 | prospectiv eOnly="tru e" | |
53 | > | |
54 | ||
55 | <drugDrugC heck /> | |
56 | ||
57 | ||
58 | <drugThera pyCheck /> | |
59 | ||
60 | ||
61 | <drugDoseC heck> | |
62 | ||
63 | <demograph ics | |
64 | ||
65 | ageInDays= "8030" | |
66 | ||
67 | weightInKG ="83.2" | |
68 | ||
69 | bodySurfac eAreaInSqM ="1.949235 " | |
70 | /> | |
71 | ||
72 | </drugDose Check> | |
73 | ||
74 | </checks> | |
75 | ||
76 | ||
77 | <prospecti veDrugs> | |
78 | ||
79 | <drug | |
80 | ||
81 | gcnSeqNo=" 111111" | |
82 | ||
83 | ien="79756 71" | |
84 | ||
85 | orderNumbe r="Z;1;Pro spect" | |
86 | > | |
87 | ||
88 | <doseInfor mation> | |
89 | ||
90 | <specific> | |
91 | ||
92 | <doseType> | |
93 | MAINTENANC E | |
94 | </doseType > | |
95 | ||
96 | <doseAmoun t> | |
97 | 2 | |
98 | </doseAmou nt> | |
99 | ||
100 | <doseUnit> | |
101 | MG | |
102 | </doseUnit > | |
103 | ||
104 | <doseRate> | |
105 | DAY | |
106 | </doseRate > | |
107 | ||
108 | <frequency > | |
109 | 4 | |
110 | </frequenc y> | |
111 | ||
112 | <duration> | |
113 | 10 | |
114 | </duration > | |
115 | ||
116 | <durationR ate> | |
117 | DAY | |
118 | </duration Rate> | |
119 | ||
120 | <route> | |
121 | ORAL | |
122 | </route> | |
123 | ||
124 | </specific > | |
125 | ||
126 | </doseInfo rmation> | |
127 | ||
128 | </drug> | |
129 | ||
130 | <drug | |
131 | ||
132 | gcnSeqNo=" 222222" | |
133 | ||
134 | ien="36377 451" | |
135 | ||
136 | orderNumbe r="Z;2;Pro spect" | |
137 | > | |
138 | ||
139 | <doseInfor mation> | |
140 | ||
141 | <specific> | |
142 | ||
143 | <doseType> | |
144 | MAINTENANC E | |
145 | </doseType > | |
146 | ||
147 | <doseUnit> | |
148 | MG | |
149 | </doseUnit > | |
150 | ||
151 | <doseRate> | |
152 | DAY | |
153 | </doseRate > | |
154 | ||
155 | <frequency > | |
156 | 2 | |
157 | </frequenc y> | |
158 | ||
159 | <duration> | |
160 | 30 | |
161 | </duration > | |
162 | ||
163 | <durationR ate> | |
164 | DAY | |
165 | </duration Rate> | |
166 | ||
167 | <route> | |
168 | TOPICAL | |
169 | </route> | |
170 | ||
171 | </specific > | |
172 | ||
173 | </doseInfo rmation> | |
174 | ||
175 | </drug> | |
176 | ||
177 | </prospect iveDrugs> | |
178 | ||
179 | ||
180 | <medicatio nProfile> | |
181 | ||
182 | <drug | |
183 | ||
184 | gcnSeqNo=" 333333" | |
185 | ||
186 | ien="12387 764" | |
187 | ||
188 | orderNumbe r="A3333" | |
189 | /> | |
190 | ||
191 | <drug | |
192 | ||
193 | gcnSeqNo=" 444444" | |
194 | ||
195 | ien="77733 452" | |
196 | ||
197 | orderNumbe r="B3333" | |
198 | /> | |
199 | ||
200 | <drug | |
201 | ||
202 | gcnSeqNo=" 555555" | |
203 | ||
204 | ien="88100 888" | |
205 | ||
206 | orderNumbe r="CCC4444 " | |
207 | /> | |
208 | ||
209 | </medicati onProfile> | |
210 | ||
211 | </drugChec k> | |
212 | ||
213 | </Body> | |
214 | </PEPSRequ est> |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.